These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32217290)

  • 1. Cost-benefit impact of free asthma medication provision for the pediatric population.
    Koltermann V; Friedrich FO; Fensterseifer AC; Ongaratto R; Pinto LA
    Respir Med; 2020 Apr; 164():105915. PubMed ID: 32217290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).
    Comaru T; Pitrez PM; Friedrich FO; Silveira VD; Pinto LA
    Respir Med; 2016 Dec; 121():21-25. PubMed ID: 27888987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients.
    Balkrishnan R; Norwood GJ; Anderson A
    Clin Ther; 1998; 20(3):567-80. PubMed ID: 9663371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative safety and costs of stepping down asthma medications in patients with controlled asthma.
    Rank MA; Liesinger JT; Branda ME; Gionfriddo MR; Schatz M; Zeiger RS; Shah ND
    J Allergy Clin Immunol; 2016 May; 137(5):1373-1379.e3. PubMed ID: 26506020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhaled corticosteroids in asthma: a medico-economic analysis of clinical trials].
    Vergnenègre A; Godard P; Atsou K; Chouaïd C
    Rev Mal Respir; 2008 Apr; 25(4):375-89. PubMed ID: 18536625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of once-daily versus twice-daily inhaled corticosteroid dosing for maintenance treatment of asthma in pediatric patients.
    Rodriguez-Martinez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2016 Jun; 53(5):538-45. PubMed ID: 26786524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbations: a cost-effectiveness analysis.
    Rodriguez-Martinez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2020 Sep; 57(9):949-958. PubMed ID: 31164017
    [No Abstract]   [Full Text] [Related]  

  • 9. A Cost-Benefit Analysis of a State-Funded Healthy Homes Program for Residents With Asthma: Findings From the New York State Healthy Neighborhoods Program.
    Gomez M; Reddy AL; Dixon SL; Wilson J; Jacobs DE
    J Public Health Manag Pract; 2017; 23(2):229-238. PubMed ID: 28121775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
    Rely K; McQuire SE; Alexandre PK; Escudero GS
    Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal nationwide study.
    Bezerra de Menezes M; Ponte EV; Bertagni Mingotti CF; Carvalho Pinto RM; Bagatin E; Bião Lima V; Vianna EO; Cruz ÁA
    Respir Med; 2020 May; 166():105950. PubMed ID: 32250873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness analysis of inhaled corticosteroid delivery for children with asthma in the emergency department.
    Andrews AL; Teufel RJ; Basco WT; Simpson KN
    J Pediatr; 2012 Nov; 161(5):903-7. PubMed ID: 22717219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
    Luskin A; Bukstein D; Kocevar VS; Yin DD
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost, morbidity, and control of asthma in Hungary: The Hunair Study.
    Herjavecz I; Nagy GB; Gyurkovits K; Magyar P; Dobos K; Nagy L; Alemao E; Ben-Joseph R
    J Asthma; 2003 Sep; 40(6):673-81. PubMed ID: 14579999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
    Doull I; Price D; Thomas M; Hawkins N; Stamuli E; Tabberer M; Gosden T; Rudge H
    Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic test that predicts response to inhaled corticosteroids in adults with asthma likely to be cost-saving.
    Wu AC; Gay C; Rett MD; Stout N; Weiss ST; Fuhlbrigge AL
    Pharmacogenomics; 2015; 16(6):591-600. PubMed ID: 25880024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
    Dasgupta R; Guest JF
    Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.